Working... Menu

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. (ROBIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01289223
Recruitment Status : Terminated (Ongoing challenges to successfully recruit the required number of subjects)
First Posted : February 3, 2011
Last Update Posted : September 3, 2018
Information provided by (Responsible Party):
Mundipharma Research Limited

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 31, 2018
  Actual Study Completion Date : July 31, 2018